Gotoh A - Search Results

1

Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model.

Ko SC, Gotoh A, Thalmann GN, Zhau HE, Johnston DA, Zhang WW, Kao C, Chung LW. Ko SC, et al. Among authors: gotoh a. Hum Gene Ther. 1996 Sep 10;7(14):1683-91. doi: 10.1089/hum.1996.7.14-1683. Hum Gene Ther. 1996. PMID: 8886839

2

Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer.

Kubo H, Gardner TA, Wada Y, Koeneman KS, Gotoh A, Yang L, Kao C, Lim SD, Amin MB, Yang H, Black ME, Matsubara S, Nakagawa M, Gillenwater JY, Zhau HE, Chung LW. Kubo H, et al. Among authors: gotoh a. Hum Gene Ther. 2003 Feb 10;14(3):227-41. doi: 10.1089/10430340360535788. Hum Gene Ther. 2003. PMID: 12639303 Clinical Trial.

3

[Clinical application for gene therapy in prostate cancer].

Gotoh A, Kamidono S, Chung LW. Gotoh A, et al. Hinyokika Kiyo. 1997 Nov;43(11):829-33. Hinyokika Kiyo. 1997. PMID: 9436031 Free article. Japanese.

4

Development of prostate-specific antigen promoter-based gene therapy for androgen-independent human prostate cancer.

Gotoh A, Ko SC, Shirakawa T, Cheon J, Kao C, Miyamoto T, Gardner TA, Ho LJ, Cleutjens CB, Trapman J, Graham FL, Chung LW. Gotoh A, et al. J Urol. 1998 Jul;160(1):220-9. J Urol. 1998. PMID: 9628654

5

In vivo suppression of osteosarcoma pulmonary metastasis with intravenous osteocalcin promoter-based toxic gene therapy.

Shirakawa T, Ko SC, Gardner TA, Cheon J, Miyamoto T, Gotoh A, Chung LW, Kao C. Shirakawa T, et al. Among authors: gotoh a. Cancer Gene Ther. 1998 Sep-Oct;5(5):274-80. Cancer Gene Ther. 1998. PMID: 9824046

6

Tissue-specific promoters in gene therapy for the treatment of prostate cancer.

Shirakawa T, Gotoh A, Wada Y, Kamidono S, Ko SC, Kao C, Gardner TA, Chung LW. Shirakawa T, et al. Among authors: gotoh a. Mol Urol. 2000 Summer;4(2):73-82. doi: 10.1089/10915360050138620. Mol Urol. 2000. PMID: 12006246 Review.

7

Cytotoxic effects of recombinant adenovirus p53 and cell cycle regulator genes (p21 WAF1/CIP1 and p16CDKN4) in human prostate cancers.

Gotoh A, Kao C, Ko SC, Hamada K, Liu TJ, Chung LW. Gotoh A, et al. J Urol. 1997 Aug;158(2):636-41. J Urol. 1997. PMID: 9224383

8

Chemogene therapy: osteocalcin promoter-based suicide gene therapy in combination with methotrexate in a murine osteosarcoma model.

Cheon J, Ko SC, Gardner TA, Shirakawa T, Gotoh A, Kao C, Chung LW. Cheon J, et al. Among authors: gotoh a. Cancer Gene Ther. 1997 Nov-Dec;4(6):359-65. Cancer Gene Ther. 1997. PMID: 9408606

9

Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells.

Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M, Gotoh A, Weksler B, Zhau HE, Chung LW. Shigemura K, et al. Among authors: gotoh a. Cancer. 2007 Apr 1;109(7):1279-89. doi: 10.1002/cncr.22551. Cancer. 2007. PMID: 17326044 Free article.

10

Reactive oxygen species mediate androgen receptor- and serum starvation-elicited downstream signaling of ADAM9 expression in human prostate cancer cells.

Shigemura K, Sung SY, Kubo H, Arnold RS, Fujisawa M, Gotoh A, Zhau HE, Chung LW. Shigemura K, et al. Among authors: gotoh a. Prostate. 2007 May 15;67(7):722-31. doi: 10.1002/pros.20565. Prostate. 2007. PMID: 17342749

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

455 results

Search Page

Filters